The selective A2A receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemia. (Q34489136)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The selective A2A receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemia. |
scientific article |
Statements
The selective A2A receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemia (English)
Marco Gianfriddo
Maria Giuliana Vannucchi
Sara Cipriani
Pier Giovanni Baraldi
Maria Grazia Giovannini
Felicita Pedata
26 January 2006